PureTech Health plc
PRTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 45% | 59.3% | -79.1% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 26% | -48.1% | -6,546.2% | -1,007% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | 774.3% | -349.2% | -9,038.9% | 267.6% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 1,108.3% | -1,972.9% | -2,409.3% | -606.9% |
| EPS Diluted | 2 | -2.4 | -1.8 | -2.1 |
| % Growth | 183.3% | -33.3% | 14.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |